Summary
The fund seeks capital appreciation by investing in mid-size companies in the United States.
The investment process starts with companies in the benchmark index and is designed to highlight with above-average earnings growth outlook.
The team uses fundamental analysis to identify companies with a positive catalyst for growth, such as a new product, acquisition, divestiture, restructuring or change in the marketplace. The team also evaluates the roles and capabilities of management.
The fund invests across variou
Link
Directors
Mar 12, 2024- Liana Marante
- Krishna K. Memani
- Keith B. Jarrett
- John Carter
- Jerry A. Webman
- Deborah L. Talbot
Chief Compliance Officer
- Ludmila Chwazik
Fund Manager(s)
Price
Company Name |
Holding |
| Cencora Inc | 2 % |
| Baker Hughes Co | 1.88 % |
| Ares Management Corp | 1.64 % |
| Booz Allen Hamilton Holding Co | 1.64 % |
| Axon Enterprise Inc | 1.55 % |
| Antero Resources Corp | 0.93 % |
| Align Technology Inc | 0.86 % |
| Carlyle Group Inc/The | 0.79 % |
| Alnylam Pharmaceuticals Inc | 0.71 % |
| BioMarin Pharmaceutical Inc | 0.65 % |
| More |
Documents
Performance
YTD
4.4%
3 Year
-27.34%
5 Year
19.21%
Best
48.62%
1999
Worst
-38.91%
2008
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | 9.4% | 6.6% | -10.5% | -1.2% | -20.5% | 17.4% | 4.4% | 8.6% | -2.8% | 7.8% |
| Q2 | -7.4% | 6% | -18.8% | 21.4% | 32.7% | 6.7% | 5.8% | 6.6% | 2.7% | 0.4% |
| Q3 | - | -6.5% | -1.7% | -9.7% | 9.6% | -1.7% | 7.7% | 4.9% | 5.1% | -9.8% |
| Q4 | - | 1.9% | 2.3% | 2.7% | 6.3% | 4.6% | -19.4% | 6.4% | 1.7% | 4.7% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | -0.1% | 7.1% | 2.3% | -7.8% | - | - | - | - | - | - | - | - |
| 2023 | 8.3% | -2.3% | 0.7% | -1.8% | -0.3% | 8.2% | 2.1% | -2.5% | -6% | -5% | 10.2% | -3.3% |
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 4% | 7% | -27% | 0% | 37% | 32% | -6% | 30% | 0% | 2% |
Alpha
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
|---|---|---|---|---|---|---|---|---|---|---|
| HAGAX | 4% | 7% | -27% | - | 37% | 32% | -6% | 30% | - | 2% |
| Russell Midcap | 4% | 25% | -27% | 12% | 35% | 34% | -6% | 24% | 6% | -1% |
| Alpha | 0% | -18% | 0% | - | 2% | -3% | -1% | 6% | - | 3% |